Indeed, it is known that Gadd45α deficiency sensitizes epithelial cancer cells to ionizing radiation in vivo [43], implicating cytoprotective genes such as Gadd45a as potential drug targets in management of cancer radiotherapy treatments. The gene discussed is GADD45A; the disease is cancer.